Related Experiment Videos
Renal transplantation: experience in Australia.
Golam Muin Uddin1, Elisabeth M Hodson
1Banga Bandhu Sheikh Mujib Medical University, P.G. Hospital, Dhaka, Bangladesh. golamu@dhaka.net
Indian Journal of Pediatrics
|April 1, 2004
Summary
Pediatric renal transplantation offers high survival rates for children with end-stage renal failure. Chronic rejection is the primary challenge impacting long-term graft survival in pediatric kidney transplant recipients.
Area of Science:
- Pediatric Nephrology
- Transplantation Immunology
- Pediatric Urology
Background:
- End-stage renal failure (ESRF) in children necessitates renal replacement therapy.
- Renal transplantation is a viable option for pediatric ESRF, aiming to improve survival and quality of life.
- Understanding long-term outcomes is crucial for optimizing pediatric kidney transplant protocols.
Purpose of the Study:
- To evaluate the outcomes of renal transplantation in children under 15 years old.
- To assess graft and patient survival rates following pediatric renal allografts.
- To identify major causes of graft loss in pediatric kidney transplant recipients.
Main Methods:
- Retrospective review of patient records and hospital renal registry data.
- Analysis of 64 renal transplants performed in 57 children between 1983 and 1997.
- Comparison of immunosuppressive regimens including Azathioprine, Prednisone, and Cyclosporine A.
Main Results:
- 10-year graft survival was 64%, with patient survival at 87%.
- Chronic rejection was the leading cause of graft loss (68%), followed by recurrence of primary disease.
- Transplanted children demonstrated good functional recovery, with most school-aged children attending school full-time.
Conclusions:
- Renal transplantation is a successful treatment for pediatric end-stage renal failure, offering high survival and improved life functioning.
- Chronic rejection remains a significant barrier to long-term graft success in pediatric kidney transplantation.
- Continued research into managing chronic rejection is vital for enhancing outcomes in pediatric renal allograft recipients.